At this year’s CNS Summit, clinical trial leaders from across the industry gathered to discuss some of the greatest challenges they’re facing today and the innovations that have helped tackle them. Topics included the latest approaches to Decentralized Clinical Trials (DCTs), recent advancements in AI and ML, and strategies to increase trial diversity and inclusion. Inato’s own Chris Kreitel spoke about how reimagining the site selection process can reduce competition and accelerate timelines while expanding patient access.
“[After working in feasibility], it started to become evident to us that the site selection process is broken - it doesn’t work,” Kreitel said. “We heard from smaller, community research practices and from sponsors about what they’re looking for and realized there’s a disconnect.”
Learn how Inato's Marketplace approach resolves this disconnect by empowering community sites to raise their hands for the trials that are best for them. Watch the full session now: https://vimeo.com/645562984